BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27506947)

  • 1. G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway.
    Zhang K; Hu Z; Qi H; Shi Z; Chang Y; Yao Q; Cui H; Zheng L; Han Y; Han X; Zhang Z; Chen T; Hong W
    Oncotarget; 2016 Sep; 7(36):58315-58330. PubMed ID: 27506947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells.
    Wang J; Hong Y; Shao S; Zhang K; Hong W
    Biochem Biophys Res Commun; 2018 Nov; 506(3):590-596. PubMed ID: 30366669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells.
    Mobraten K; Haug TM; Kleiveland CR; Lea T
    Lipids Health Dis; 2013 Jul; 12():101. PubMed ID: 23849180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation.
    Zhang K; Chang Y; Shi Z; Han X; Han Y; Yao Q; Hu Z; Cui H; Zheng L; Han T; Hong W
    Sci Rep; 2016 Jul; 6():30029. PubMed ID: 27435808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR120 is not required for ω-3 PUFAs-induced cell growth inhibition and apoptosis in breast cancer cells.
    Zhu S; Jiang X; Jiang S; Lin G; Gong J; Chen W; He Z; Chen YQ
    Cell Biol Int; 2018 Feb; 42(2):180-186. PubMed ID: 28980737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anticancer Role of Omega-3 Polyunsaturated Fatty Acids was Closely Associated with the Increase in Genomic DNA Hydroxymethylation.
    Huang Q; Mo M; Zhong Y; Yang Q; Zhang J; Ye X; Zhang L; Cai C
    Anticancer Agents Med Chem; 2019; 19(3):330-336. PubMed ID: 30338745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of n-3/n-6 PUFAs ratio suppresses mTORC1 and prevents colorectal carcinogenesis associated with APC mutation.
    Liu M; Zhou L; Zhang B; He M; Dong X; Lin X; Jia C; Bai X; Dai Y; Su Y; Zou Z; Zheng H
    Oncotarget; 2016 Nov; 7(47):76944-76954. PubMed ID: 27769066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1.
    Sheng H; Chen X; Liu B; Li P; Cao W
    Anticancer Agents Med Chem; 2016; 16(9):1085-92. PubMed ID: 27025656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.
    O'Connell TD; Block RC; Huang SP; Shearer GC
    J Mol Cell Cardiol; 2017 Feb; 103():74-92. PubMed ID: 27986444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells.
    Chai Y; Xiang K; Wu Y; Zhang T; Liu Y; Liu X; Zhen W; Si Y
    Med Sci Monit; 2018 Dec; 24():9251-9258. PubMed ID: 30566960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
    Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
    EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer.
    Cheung P; Xiol J; Dill MT; Yuan WC; Panero R; Roper J; Osorio FG; Maglic D; Li Q; Gurung B; Calogero RA; Yilmaz ÖH; Mao J; Camargo FD
    Cell Stem Cell; 2020 Oct; 27(4):590-604.e9. PubMed ID: 32730753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation.
    Sam MR; Ahangar P; Nejati V; Habibian R
    Cell Oncol (Dordr); 2016 Feb; 39(1):69-77. PubMed ID: 26671842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.
    Chen Q; Zhang N; Xie R; Wang W; Cai J; Choi KS; David KK; Huang B; Yabuta N; Nojima H; Anders RA; Pan D
    Genes Dev; 2015 Jun; 29(12):1285-97. PubMed ID: 26109051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
    Xu H; Li J; Chen H; Ghishan FK
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Han Y; Tang Z; Zhao Y; Li Q; Wang E
    Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.